Clinical Trial Update: ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults [Phase 2]

View source ↗

Summary

Enveda Therapeutics is conducting a Phase 2 trial of ENV-294 for moderate-to-severe asthma in adults, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ENV-294

Snippet

Sponsor: Enveda Therapeutics | Conditions: Asthma | Phase 2 | Status: RECRUITING